COMBS v. BAYER AG
Citations
- 2026 OK CIV APP 17
Syllabus
¶1 Plaintiff Ginger Casper Combs (Combs) appeals summary judgment in favor Defendant Bayer HealthCare Pharmaceuticals Inc. on her claims for strict liability failure to warn and defective design or manufacture; negligence; various claims of fraud or negligent misrepresentation; and negligent training or education, all arising from production and/or distribution of \Magnevist.\ Magnevist is an FDA-approved contrast agent. Combs received an injection of Magnevist in 2016 to undergo magnetic resonance imaging (MRI). The crux of her claim is that Magnevist is made from gadolinium, which can be retained in the body after injection. She asserts that retention of this substance in the body causes a condition known as Gadolinium Deposition Disease (GDD), and that her injection caused a wide variety of serious and prolonged symptoms or reactions. She asserts that Bayer failed to adequately warn of this danger.
Sourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.